The role of baseline Ga-68 DOTATATE positron emission tomography/computed tomography in the prediction of response to fixed-dose peptide receptor radionuclide therapy with Lu-177 DOTATATE

SOYDAL Ç., Peker A., ÖZKAN E., KÜÇÜK N. Ö., KIR K. M.

TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.46, sa.2, ss.409-413, 2016 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 46 Sayı: 2
  • Basım Tarihi: 2016
  • Doi Numarası: 10.3906/sag-1412-11
  • Dergi Adı: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.409-413
  • Anahtar Kelimeler: Peptide receptor radionuclide therapy, Ga-68 DOTATATE positron emission tomography/computed tomography, treatment response, NEUROENDOCRINE TUMORS, DIAGNOSIS
  • Ankara Üniversitesi Adresli: Evet

Özet

Background/aim: To describe the role of baseline gallium (Ga)-68 DOTATATE positron emission tomography (PET)/computed tomography (CT) in the prediction of the response to peptide receptor radionuclide therapy (PRRT) using lutetium (Lu)-177 DOTATATE.